The Japanese prime minister forces the country to use Avigan as a coronary treatment

Japan's prime minister is pushing his country to use the Avigan drug as treatment for the coronary, despite lack of evidence that works in treatment. Shinzo Abe said Monday he wanted the drug approved for anti-use. COVID-19 by the end of the month, despite acknowledging that there were side effects [...]
Japan's prime minister is pushing his country to use the Avigan drug as treatment for the coronary, despite lack of evidence that works in treatment.
Shinzo Abe said Monday he wanted the drug approved for anti-use. COVID-19 by the end of the month, despite acknowledging that there were side effects that caused birth defects, the Daily Mail writes, broadcasts the news.net.
Avigan is the name of the brand for favipiraver and has been used in the outbreak of flu and Ebola treatment. Adopted for use in Japan in 2014, the favipiraver functions by blocking the virus's ability to breed within a cell.
Medicament has been shown in animal studies that affect the development of the fetus, meaning that it is not given to pregnant women, and some doctors say that they do not recommend it for children or teenagers.
Experts increasingly promote medicine by Abe. He has supported the drug with $130 million to triple existing reserves.
However, without studies to confirm Abe's expectations, there is only anecdotal evidence to support his claims regarding Avigan.












